Drug: LAMICTAL Injury: Hepatic function abnormal Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
116136405 | LAMICTAL | Hepatic function abnormal | GLAXOSMITHKLINE | 32.55 YR | F | 53 KG | 20160826 | JP |
116897404 | LAMICTAL | Hepatic function abnormal | GLAXOSMITHKLINE | 43.00 YR | F | 0 | 20160830 | JP |
126409401 | LAMICTAL | Hepatic function abnormal | GLAXOSMITHKLINE | 16.55 YR | F | 50 KG | 20160810 | JP |
127098991 | LAMICTAL | Hepatic function abnormal | GLAXOSMITHKLINE | 43.00 YR | M | 72 KG | 20160902 | JP |
127219872 | LAMICTAL | Hepatic function abnormal | GLAXOSMITHKLINE | 13.00 YR | F | 53 KG | 20160908 | CN |
127459021 | LAMICTAL | Hepatic function abnormal | GLAXOSMITHKLINE | 61.00 YR | M | 51 KG | 20160915 | JP |
Total Records: 6 Number of Pages: 1